Suppr超能文献

淀粉样 SARS-COV-2 蛋白片段对 α-突触核蛋白单体和纤维的影响。

Effect of an Amyloidogenic SARS-COV-2 Protein Fragment on α-Synuclein Monomers and Fibrils.

机构信息

Department of Chemistry & Biochemistry, University of Oklahoma, Norman, Oklahoma 73019, United States.

出版信息

J Phys Chem B. 2022 May 26;126(20):3648-3658. doi: 10.1021/acs.jpcb.2c01254. Epub 2022 May 17.

Abstract

Aggregates of α-synuclein are thought to be the disease-causing agent in Parkinson's disease. Various case studies have hinted at a correlation between COVID-19 and the onset of Parkinson's disease. For this reason, we use molecular dynamics simulations to study whether amyloidogenic regions in SARS-COV-2 proteins can initiate and modulate aggregation of α-synuclein. As an example, we choose the nine-residue fragment SFYVYSRVK (SK9), located on the C-terminal of the envelope protein of SARS-COV-2. We probe how the presence of SK9 affects the conformational ensemble of α-synuclein monomers and the stability of two resolved fibril polymorphs. We find that the viral protein fragment SK9 may alter α-synuclein amyloid formation by shifting the ensemble toward aggregation-prone and preferentially rod-like fibril seeding conformations. However, SK9 has only a small effect on the stability of pre-existing or newly formed fibrils. A potential mechanism and key residues for potential virus-induced amyloid formation are described.

摘要

α- 突触核蛋白的聚集体被认为是帕金森病的致病因素。各种病例研究表明,COVID-19 与帕金森病的发病之间存在相关性。出于这个原因,我们使用分子动力学模拟来研究 SARS-COV-2 蛋白中的淀粉样蛋白区域是否可以引发和调节 α- 突触核蛋白的聚集。为此,我们选择了位于 SARS-COV-2 包膜蛋白 C 末端的九肽 SFYVYSRVK (SK9) 作为示例。我们探究了 SK9 的存在如何影响 α- 突触核蛋白单体的构象集合体以及两种解析纤维态多晶型的稳定性。我们发现,病毒蛋白片段 SK9 可能通过将集合体转向易于聚集和优先形成棒状纤维原种子构象来改变 α- 突触核蛋白的淀粉样形成。然而,SK9 对现有或新形成的纤维的稳定性只有很小的影响。描述了潜在的病毒诱导淀粉样形成的机制和关键残基。

相似文献

1
Effect of an Amyloidogenic SARS-COV-2 Protein Fragment on α-Synuclein Monomers and Fibrils.
J Phys Chem B. 2022 May 26;126(20):3648-3658. doi: 10.1021/acs.jpcb.2c01254. Epub 2022 May 17.
2
Effect of an amyloidogenic SARS-COV-2 protein fragment on α-synuclein monomers and fibrils.
bioRxiv. 2022 Feb 23:2022.02.21.481360. doi: 10.1101/2022.02.21.481360.
3
SARS-COV-2 spike protein fragment eases amyloidogenesis of α-synuclein.
J Chem Phys. 2023 Jul 7;159(1). doi: 10.1063/5.0157331.
4
Moderate Binding between Two SARS-CoV-2 Protein Segments and α-Synuclein Alters Its Toxic Oligomerization Propensity Differently.
J Phys Chem Lett. 2022 Nov 17;13(45):10642-10648. doi: 10.1021/acs.jpclett.2c02278. Epub 2022 Nov 10.
8
SARS-CoV-2-Mimicking Pseudoviral Particles Accelerate α-Synuclein Aggregation In Vitro.
ACS Chem Neurosci. 2024 Jan 17;15(2):215-221. doi: 10.1021/acschemneuro.3c00468. Epub 2023 Dec 22.
9
SARS-COV-2 Spike Protein Fragment eases Amyloidogenesis of α-Synuclein.
bioRxiv. 2023 May 8:2023.05.06.539715. doi: 10.1101/2023.05.06.539715.

引用本文的文献

2
Effect of a SARS-CoV-2 Protein Fragment on the Amyloidogenic Propensity of Human Islet Amyloid Polypeptide.
ACS Chem Neurosci. 2024 Dec 18;15(24):4431-4440. doi: 10.1021/acschemneuro.4c00473. Epub 2024 Nov 24.
4
Molecular Insight into the Effect of HIV-TAT Protein on Amyloid-β Peptides.
ACS Omega. 2024 Jun 13;9(25):27480-27491. doi: 10.1021/acsomega.4c02643. eCollection 2024 Jun 25.
5
Coupling of SARS-CoV-2 to Aβ Amyloid Fibrils.
ACS Omega. 2024 Feb 15;9(8):9295-9299. doi: 10.1021/acsomega.3c08481. eCollection 2024 Feb 27.
8
Spike Protein Fragments Promote Alzheimer's Amyloidogenesis.
ACS Appl Mater Interfaces. 2023 Aug 30;15(34):40317-40329. doi: 10.1021/acsami.3c09815. Epub 2023 Aug 16.
9
SARS-COV-2 spike protein fragment eases amyloidogenesis of α-synuclein.
J Chem Phys. 2023 Jul 7;159(1). doi: 10.1063/5.0157331.
10
SARS-COV-2 Spike Protein Fragment eases Amyloidogenesis of α-Synuclein.
bioRxiv. 2023 May 8:2023.05.06.539715. doi: 10.1101/2023.05.06.539715.

本文引用的文献

1
Amyloidogenesis of SARS-CoV-2 Spike Protein.
J Am Chem Soc. 2022 May 25;144(20):8945-8950. doi: 10.1021/jacs.2c03925. Epub 2022 May 17.
2
Interconversion between Serum Amyloid A Native and Fibril Conformations.
ACS Omega. 2022 Mar 30;7(14):12186-12192. doi: 10.1021/acsomega.2c00566. eCollection 2022 Apr 12.
3
Interactions between SARS-CoV-2 N-Protein and α-Synuclein Accelerate Amyloid Formation.
ACS Chem Neurosci. 2022 Jan 5;13(1):143-150. doi: 10.1021/acschemneuro.1c00666. Epub 2021 Dec 3.
4
Modeling SARS-CoV-2 proteins in the CASP-commons experiment.
Proteins. 2021 Dec;89(12):1987-1996. doi: 10.1002/prot.26231. Epub 2021 Oct 5.
5
The N terminus of α-synuclein dictates fibril formation.
Proc Natl Acad Sci U S A. 2021 Aug 31;118(35). doi: 10.1073/pnas.2023487118.
6
Presence of a SARS-CoV-2 Protein Enhances Amyloid Formation of Serum Amyloid A.
J Phys Chem B. 2021 Aug 19;125(32):9155-9167. doi: 10.1021/acs.jpcb.1c04871. Epub 2021 Aug 9.
7
The clinical course and prognostic factors of severe COVID-19 in Wuhan, China: A retrospective case-control study.
Medicine (Baltimore). 2021 Feb 26;100(8):e23996. doi: 10.1097/MD.0000000000023996.
8
Stability of Human Serum Amyloid A Fibrils.
J Phys Chem B. 2020 Nov 25;124(47):10708-10717. doi: 10.1021/acs.jpcb.0c08280. Epub 2020 Nov 16.
9
Infectious hypothesis of Alzheimer disease.
PLoS Pathog. 2020 Nov 12;16(11):e1008596. doi: 10.1371/journal.ppat.1008596. eCollection 2020 Nov.
10
Is COVID-19 a Perfect Storm for Parkinson's Disease?
Trends Neurosci. 2020 Dec;43(12):931-933. doi: 10.1016/j.tins.2020.10.009. Epub 2020 Oct 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验